MR-proADM as prognostic factor of outcome in COVID-19 patients

MR-proADM as prognostic factor of outcome in COVID-19 patients

Abstract Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis, septic shock and organ failure. It can be induced by bacteria, fungi or viruses. We hypothesized that the assessment of MR-pr...

Full description

Bibliographic Details
Main Authors: Emanuela Sozio, Carlo Tascini, Martina Fabris, Federica D’Aurizio, Chiara De Carlo, Elena Graziano, Flavio Bassi, Francesco Sbrana, Andrea Ripoli, Alberto Pagotto, Alessandro Giacinta, Valentina Gerussi, Daniela Visentini, Paola De Stefanis, Maria Merelli, Kordo Saeed, Francesco Curcio
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84478-1

Internet

https://doi.org/10.1038/s41598-021-84478-1

Similar Items